Literature DB >> 10636375

15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.

.   

Abstract

In a randomised, double-blind comparison of a maternal short regimen of oral zidovudine with placebo in West Africa the 15-month efficacy of zidovudine in preventing mother-to-child transmission of HIV-1 infection was estimated at 30% (95% CI -2 to 52).

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10636375

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  What can we do to reduce mother to child transmission of HIV?

Authors:  James McIntyre; Glenda Gray
Journal:  BMJ       Date:  2002-01-26

Review 2.  Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Authors:  A Bardsley-Elliot; C M Perry
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 3.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Authors:  Louise Kuhn; Ingrid Peterson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.

Authors:  L Kuhn; S Meddows-Taylor; G Gray; D Trabattoni; M Clerici; G M Shearer; C Tiemessen
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 6.  Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Authors:  Nila Bhana; Douglas Ormrod; Caroline M Perry; David P Figgitt
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery.

Authors:  L Mandelbrot; P Msellati; N Meda; V Leroy; R Likikouët; P Van de Perre; L Dequae-Merchadoux; F Sylla-Koko; A Ouangre; T Ouassa; R Ramon; L Gautier-Charpentier; M Cartoux; M Dosso; F Dabis; C Welffens-Ekra
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

8.  18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.

Authors:  Jérôme Harambat; Patricia Fassinou; Renaud Becquet; Pety Touré; François Rouet; François Dabis; Philippe Msellati; Stéphane Blanche; Marguerite Timité-Konan; Roger Salamon; Valériane Leroy
Journal:  BMC Public Health       Date:  2008-05-20       Impact factor: 3.295
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.